Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Turner, Leigh  [Clear All Filters]
2024
Turner L, Wang JChieng, Martinez JRamon, Najjar S, Arachchilage TRajapaksha, Sahrai V. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era. Cytotherapy. 2024.
2023
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, et al. International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023;25(9):920-929.
Zettler PJ, Ikonomou L, Levine AD, Turner L, Grilley B, Roxland BE. An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies. Cytotherapy. 2023.
Turner L, Martinez JRamon, Najjar S, Arachchilage TRajapaksha, Sahrai V, Wang JChieng. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies. Regen Med. 2023.
2021
Turner L. The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. Cell Stem Cell. 2021;28(11):1891-1895.
Turner L, Munsie M, Levine AD, Ikonomou L. Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. Stem Cell Reports. 2021.
Lovell-Badge R, Anthony E, Barker RA, Bubela T, Brivanlou AH, Carpenter M, R Charo A, Clark A, Clayton E, Cong Y, et al. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports. 2021.
Turner L. ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions. Stem Cell Reports. 2021.
2020
Turner L. Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19. Cell Stem Cell. 2020.
2019
Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases. Ann Am Thorac Soc. 2019.
2018
Snyder J, Turner L. Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns. Regen Med. 2018;13(4):375-384.